Avalon Pharma shareholders OK 2026 interim dividends mandate

Avalon Pharma’s shareholders also elected board members for the new four-year term.

Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) shareholders authorized the board of directors to pay interim dividends for 2026, on a semiannual basis.

 

In a statement to Tadawul, the company said shareholders also elected board members for the new four-year term ending on April 15, 2030.

 

The board members are Ahmed Al Tabbaa, Hisham Attar, Mohamed Al Ghannam, Omar Al Jaroudi and Alexander Triebnigg.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request